Bispecific Antibodies in Cancer Care: What to Know, What to Expect - Tara Graff, DO, MS скачать в хорошем качестве

Bispecific Antibodies in Cancer Care: What to Know, What to Expect - Tara Graff, DO, MS

Cancer Nation’s Webinar Series presents Bispecific Antibodies in Cancer Care: What to Know, What to Expect, with Dr. Tara Graff. Bispecific antibodies are a newer type of immunotherapy cancer treatment, currently more often used in later lines of therapy, mainly in blood cancers such as lymphomas and myelomas. This discussion will help patients and caregivers make sense of Bispecific antibodies — what they are, how they’re used in real-world cancer care, and what people can expect during the early phases of treatment. Dr. Graff, Director of Clinical Research at Mission Cancer and Blood in Iowa, breaks down common symptoms and side effects, how treatment may feel day to day, and how to communicate clearly and confidently with your care team. She also discusses what survivorship may look like after treatment and what questions patients and caregivers may want to ask along the way. Following Dr. Graff’s presentation, Cancer Nation CEO Shelley Fuld Nasso moderates a Q&A session that includes questions from the webinar audience of patients, advocates, and professionals. Find the slide deck and other resources on our website: https://canceradvocacy.org/webinar-bi... 00:00 Introducing Dr. Tara Graff 01:39 Why this topic matters 03:21 What are Bispecific Antibodies? When are they used? 05:02 Bispecifics in Lymphoma & Myeloma 09:47 Patient Clinical Journey, Consensus Guidelines 14:29 Reported Side Effects, Toxicities 18:37 Clinical Side Effect Mitigation 21:24 What patients & caregivers can expect, common questions 27:36 Infection Risk, Late Toxicity 29:20 Resources & Education for Patients 31:00 Q&A 31:43 Providing Bispecifics in communities vs. cancer centers 37:26 What are the responsibilities for caregivers? 41:06 Bispecifics Clinical Trials of other cancer types 42:39 Survival rate discussion 45:05 Where do bispecifics fit among other treatment options? 48:54 How do you monitor for side effects? 53:29 How do your patients compare this treatment with others? This webinar is presented by Cancer Nation, and supported by an unrestricted educational grant from Genmab.